Logo image of ADPT

ADAPTIVE BIOTECHNOLOGIES (ADPT) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ADPT - US00650F1093 - Common Stock

17.52 USD
-0.26 (-1.46%)
Last: 1/16/2026, 8:00:00 PM
17.52 USD
0 (0%)
After Hours: 1/16/2026, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
ADPT revenue by date.ADPT revenue by date.
185.3M
20.09%
170.276M
-8.11%
178.957M
5.10%
269.97M
50.86%
271.41M
0.53%
333.96M
23.05%
397.94M
19.16%
484.91M
21.86%
571.91M
17.94%
EBITDA
YoY % growth
ADPT ebitda by date.ADPT ebitda by date.
-177.7M
8.87%
-179.375M
-0.94%
-136.088M
24.13%
-13.432M
90.13%
-36.454M
-171.40%
17.176M
147.12%
87.72M
410.71%
42.228M
-51.86%
N/A
EBIT
YoY % growth
ADPT ebit by date.ADPT ebit by date.
-198.6M
4.98%
-201.606M
-1.51%
-155.344M
22.95%
-74.132M
52.28%
-90.497M
-22.08%
-55.968M
38.15%
-22.406M
59.97%
-31.518M
-40.67%
-11.424M
63.75%
Operating Margin
ADPT operating margin by date.ADPT operating margin by date.
-107.18%-118.40%-86.81%-27.46%-33.34%-16.76%-5.63%-6.50%-2.00%
EPS
YoY % growth
ADPT eps by date.ADPT eps by date.
-1.41
4.08%
-1.38
2.13%
-1.09
21.01%
-0.50
54.26%
-0.59
-17.65%
-0.37
37.39%
-0.15
60.19%
-0.19
-32.59%
-0.08
57.89%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth
-0.18
19.62%
-0.18
12.03%
-0.15
10.75%
-0.15
-342.25%
-0.13
30.34%
-0.13
27.54%
-0.07
56.30%
-0.10
33.33%
-0.07
48.51%
-0.05
60.00%
0.01
115.38%
-0.08
15.79%
Revenue
Q2Q % growth
60.579M
27.64%
59.65M
13.74%
66.468M
12.89%
70.264M
-25.23%
74.239M
22.55%
71.043M
19.10%
84.915M
27.75%
85.272M
21.36%
90.066M
21.32%
92.004M
29.50%
104.04M
22.52%
99.654M
16.87%
EBITDA
Q2Q % growth
-7.825M
45.27%
-9.228M
62.90%
-5.059M
67.99%
3.998M
-83.29%
2.137M
127.31%
-2.04M
77.89%
10.261M
302.82%
14.015M
250.55%
19.237M
800.19%
N/AN/AN/A
EBIT
Q2Q % growth
-26.704M
21.46%
-27.774M
6.18%
-22.132M
11.60%
-22.097M
-314.74%
-20.066M
24.86%
-20.212M
27.23%
-10.053M
54.58%
-14.578M
34.03%
-9.98M
50.27%
N/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.06
127.27%
-0.150.21140.22%
Q2 2025
Q2Q % growth
-0.17
45.16%
-0.240.0730.19%
Q1 2025
Q2Q % growth
-0.20
39.39%
-0.300.1032.96%
Q4 2024
Q2Q % growth
-0.23
23.33%
-0.260.0312.00%
Q3 2024
Q2Q % growth
-0.22
37.14%
-0.290.0724.98%
Q2 2024
Q2Q % growth
-0.31
6.06%
-0.340.038.94%
Q1 2024
Q2Q % growth
-0.33
17.50%
-0.350.025.24%
Q4 2023
Q2Q % growth
-0.30
-7.14%
-0.340.0411.21%
Q3 2023
Q2Q % growth
-0.35
-9.37%
-0.350.00-1.25%
Q2 2023
Q2Q % growth
-0.33
10.81%
-0.350.026.66%
Q1 2023
Q2Q % growth
-0.40
9.09%
-0.38-0.02-4.08%
Q4 2022
Q2Q % growth
-0.28
34.88%
-0.350.0720.75%
Q3 2022
Q2Q % growth
-0.32
20.00%
-0.380.0616.56%
Q2 2022
Q2Q % growth
-0.37
-5.71%
-0.440.0715.64%
Q1 2022
Q2Q % growth
-0.44
-51.72%
-0.470.035.93%
Q4 2021
Q2Q % growth
-0.43
-30.30%
-0.460.036.61%
Q3 2021
Q2Q % growth
-0.40
-48.15%
-0.430.036.91%
Q2 2021
Q2Q % growth
-0.35
-34.62%
-0.440.0919.67%
Q1 2021
Q2Q % growth
-0.29
-16.00%
-0.420.1330.41%
Q4 2020
Q2Q % growth
-0.33 -0.30-0.03-10.47%
Q3 2020
Q2Q % growth
-0.27 -0.290.026.89%
Q2 2020
Q2Q % growth
-0.26 -0.290.0310.56%
Q1 2020
Q2Q % growth
-0.25 -0.21-0.04-19.85%
ADPT Yearly EPS VS EstimatesADPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
93.973M
102.38%
65.936M28.037M42.52%
Q2 2025
Q2Q % growth
58.879M
36.33%
50.388M8.491M16.85%
Q1 2025
Q2Q % growth
52.443M
25.24%
43.532M8.911M20.47%
Q4 2024
Q2Q % growth
47.459M
3.66%
46.955M504K1.07%
Q3 2024
Q2Q % growth
46.435M
22.46%
41.012M5.423M13.22%
Q2 2024
Q2Q % growth
43.19M
-11.72%
39.438M3.752M9.51%
Q1 2024
Q2Q % growth
41.873M
11.23%
39.56M2.313M5.85%
Q4 2023
Q2Q % growth
45.784M
-17.06%
49.427M-3.643M-7.37%
Q3 2023
Q2Q % growth
37.919M
-20.72%
43.822M-5.903M-13.47%
Q2 2023
Q2Q % growth
48.926M
12.06%
45.785M3.141M6.86%
Q1 2023
Q2Q % growth
37.647M
-2.52%
37.547M100K0.27%
Q4 2022
Q2Q % growth
55.2M
45.53%
55.8M-600K-1.08%
Q3 2022
Q2Q % growth
47.83M
21.18%
48.991M-1.161M-2.37%
Q2 2022
Q2Q % growth
43.66M
13.37%
43.004M656K1.53%
Q1 2022
Q2Q % growth
38.62M
0.47%
38.464M156K0.41%
Q4 2021
Q2Q % growth
37.93M
25.64%
37.437M493K1.32%
Q3 2021
Q2Q % growth
39.47M
50.08%
37.368M2.102M5.63%
Q2 2021
Q2Q % growth
38.51M
83.47%
31.887M6.623M20.77%
Q1 2021
Q2Q % growth
38.44M
83.84%
28.302M10.138M35.82%
Q4 2020
Q2Q % growth
30.19M 27.44M2.75M10.02%
Q3 2020
Q2Q % growth
26.3M 24.055M2.245M9.33%
Q2 2020
Q2Q % growth
20.99M 19.176M1.814M9.46%
Q1 2020
Q2Q % growth
20.91M 21.958M-1.048M-4.77%
ADPT Yearly Revenue VS EstimatesADPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -5.58% 0% 32.65%
Revenue0% -6.1% 0% 13.71%